ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

Name: ATAI Life Sciences N.V.: Is Infosys Ltd. worth buying?
Item: ATAI Life Sciences N.V.
Rating: 1.40666675
Author: Trendlyne DVM scores

about

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebuf...

3.90 0.05 (1.30%)

42.22% Fall from 52W High

3.4M

XNAS Volume

XNAS 21 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

4.2 / 100

Technically Neutral

52.1 / 100

1Yr Price target upside is 215%

11 analysts

ATAI Life Sciences N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebuf...

42.22% Fall from 52W High

SWOT Analysis

ATAI Life Sciences N.V. Live Price Chart